Genpact (NYSE:G – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 3.520-3.590 for the period, compared to the consensus earnings per share estimate of 3.450. The company issued revenue guidance of $5.0 billion-$5.1 billion, compared to the consensus revenue estimate of $5.1 billion. Genpact also updated its Q1 2025 guidance to 0.790-0.800 EPS.
Genpact Trading Down 0.1 %
Shares of Genpact stock traded down $0.04 during trading on Thursday, hitting $49.38. 1,256,998 shares of the company were exchanged, compared to its average volume of 1,325,743. The firm has a market capitalization of $8.71 billion, a P/E ratio of 13.56, a price-to-earnings-growth ratio of 1.61 and a beta of 1.20. The firm’s fifty day moving average price is $44.86 and its 200 day moving average price is $41.09. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. Genpact has a 1-year low of $30.23 and a 1-year high of $49.68.
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to analysts’ expectations of $1.19 billion. Genpact had a net margin of 14.22% and a return on equity of 21.85%. During the same period last year, the firm posted $0.67 earnings per share. As a group, sell-side analysts expect that Genpact will post 2.94 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Get Our Latest Report on Genpact
Insider Activity at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Balkrishan Kalra sold 9,000 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 35,058 shares of company stock worth $1,558,675. Insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- There Are Different Types of Stock To Invest In
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What is the Nikkei 225 index?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.